Structure-based discovery of nonhallucinogenic psychedelic analogs
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Drugs that target the human serotonin 2A receptor (5-HT 2A R) are used to treat neuropsychiatric diseases; however, many have hallucinogenic effects, hampering their use. Here, we present structures of 5-HT 2A R complexed with the psychedelic drugs psilocin (the active metabolite of psilocybin) and d -lysergic acid diethylamide (LSD), as well as the endogenous neurotransmitter serotonin and the nonhallucinogenic psychedelic analog lisuride. Serotonin and psilocin display a second binding mode in addition to the canonical mode, which enabled the design of the psychedelic IHCH-7113 (a substructure of antipsychotic lumateperone) and several 5-HT 2A R β-arrestin–biased agonists that displayed antidepressant-like activity in mice but without hallucinogenic effects. The 5-HT 2A R complex structures presented herein and the resulting insights provide a solid foundation for the structure-based design of safe and effective nonhallucinogenic psychedelic analogs with therapeutic effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, to target 5-HT 2A R, the combination of LSD and psilocybin can lead to biased activation of the mediated signaling pathway and produce antidepressant effects without the side effects of hallucinations. 387”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [387]
In the citing paper
“While LSD binds to the orthosteric site of the 5-HT 2A R, certain ergoline-like analogs of LSD bind to the 5-HT 2A R at an extended binding pocket (Cao et al., 2022).”
From Psychedelics and Neural Plasticity: Therapeutic Implications (2022) · cites this paper as Cao et al., 2022
In the citing paper
“In a separate study, the psychedelic analog IHCH-7113 and several other 5-HT 2A R b -arrestin-biased agonists also demonstrate antidepressant-like activity in mice without hallucinogenic effects (Cao et al., 2022), although their dendritic and synaptic effects remain to be elucidated.”
From Psychedelics and Neural Plasticity: Therapeutic Implications (2022) · cites this paper as Cao et al., 2022
Citations
Cites
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
Integration, scaling, space-group assignment and post-refinement
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047374 · Cited by 2,528
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201
The expanded biology of serotonin
Berger, M., Gray, J. A., & Roth, B. L. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.042307.110802 · Cited by 2,100
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698
Trial of Psilocybin versus Escitalopram for Depression
Carhart-Harris, R., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., Martell, J., Blemings, A., Erritzoe, D., & Nutt, D. J. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2032994 · Cited by 1,391
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4771-x · Cited by 970
Operational models of pharmacological agonism
Black, J. W., & Leff, P. (1983) · Proceedings of the Royal Society of London. Series B. Biological Sciences · doi:10.1098/rspb.1983.0093 · Cited by 951
Research works printed but not linked: 3
- A. S. A. T. Shulgin PIHKAL: A Chemical Love Story (Transform Press 1991).
- A. S. A. T. Shulgin TIHKAL: The Continuation (Transform Press 1997).
- 10.1073/pnas.0708862105 · DOI · Paper page
Cited by
Items 301–314 of 314
Structure-based design of subtype-selective psychedelic analogs
Li, H., Tang, L., Zhang, J., Meng, B., Cao, D., Chen, Y., Yu, J., Wang, H., Liu, Z., Wang, S., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-77658-y
Self-citationCyrano, E., Gołębiowska, J., Popik, P., Zajdel, P., & Potasiewicz, A. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111940
ESCAPE enables receptor-specific chemogenetic dissection of GPCR signaling
Matsuoka, Y., Inoue, H., Hori, T., Tran, D. P., Kitao, A., Suzuki, H., Mizuno, S., Takahashi, S., Doura, T., & Kiyonaka, S. (2026) · Cell chemical biology · doi:10.1016/j.chembiol.2026.09.008
Floris, G., Jefferson, S. J., Rondeau, J. A., Yu, A. L., Menniti, F. S., Kwan, A. C., Aquino, J. P. D., Krystal, J. H., Pittenger, C., & Kaye, A. P. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02569-x
Atomic, structural and molecular insights into GPCR ligand binding and signalling
Nemec, K., Mészáros, B., Skiniotis, G., Blanchard, S. C., & Babu, M. M. (2026) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-026-01030-7 · Cited by 1
AbouEich, H. K., Izadi, A., Lifshitz, J., Olson, D. E., & Gurkoff, G. G. (2026) · Journal of Neurotrauma · doi:10.1177/08977151261495030
Đorđević, V. V., Binić, I., Petrović, J., Stojanov, J., Mitić, Ž. J., & Veselinović, A. M. (2026) · Molecules · doi:10.3390/molecules31203764
Sustained antidepressant-like effects of psychedelics through 5-HT2AR–β-arrestin signaling
He, L., Tang, L., Cao, D., Duan, W., Yu, J., Zhang, P., Li, H., Wang, Y., Meng, B., Wang, H., et al. (2026) · Nature Neuroscience · doi:10.1038/s41593-026-02497-5
Self-citationBindingDB Entry 50016203: Discovery of β-Arrestin-Biased 25CN-NBOH-Derived 5-HT
BindingDB (2023) · UC San Diego · doi:10.7270/q2wd44j5
Flores, A., Carrasco, I. L. L., Lozano-Espinosa, M., Soriano-Agueda, L. A., Gómez-Castro, C. Z., & Franco‐Pérez, M. (2026) · Research Square · doi:10.21203/rs.3.rs-11502694/v1
Zhai, H., Wang, H., Wang, Y., & Wang, X. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03939-z
Self-citationMiranda-Azpiazu, P., Díez-Alarcia, R., Arrate, I. M., García‐Bea, A., Maldonado, R. J., Morentín, B., González‐Maeso, J., & Meana, J. J. (2026) · Neurochemistry International · doi:10.1016/j.neuint.2026.106285
Pharmacist Guide to Psilocybin and Psychedelic-Assisted Psychotherapy
Vandiver, J. W., Anderson, B. K., Suyama, T. L., & French, A. R. (2026) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxag388
Metadata
- Authors
- Cao, D., Yu, J., Wang, H., Luo, Z., Liu, X., He, L., Qi, J., Fan, L., Tang, L., Chen, Z., Li, J., Cheng, J., & Wang, S.
- Affiliations
- Chinese Academy of Sciences (CN)
- ShanghaiTech University (CN)
- Soochow University (CN)
- Corresponding author
- Cao, Dongmei
- Yu, Jing
- Wang, Huan
- Luo, Zhipu
- Liu, Xinyu
- Cheng, Jianjun
- Wang, Sheng
- ORCID
- Venue
- Science
- Published
- 2022-01-28
- Volume
- 375
- Issue
- 6579
- Pages
- 403-411
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W4210474529
- Cited by
- 312
- References
- 46
- Citations by year
- 2026: 50 · 2025: 77 · 2024: 84 · 2023: 69 · 2022: 32
- FWCI
- 59.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- 5-HT2A receptor, psilocin, LSD, lisuride, structure-based drug design, receptor-ligand complex, lumateperone, antidepressant-like effects, hallucinogenic effects
- MeSH terms
- Animals, Antidepressive Agents, Binding Sites, Hallucinations, Hallucinogens, Heterocyclic Compounds, 4 or More Rings, Humans, Ligands, Lisuride, Lysergic Acid Diethylamide, Protein Conformation, Psilocybin, Serotonin, Structure-Activity Relationship, Drug Design, Signal Transduction, Crystallography, X-Ray, Arrestin, Receptor, Serotonin, 5-HT2A, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.